Cough Assist Devices Market Report 2025

The cough assist devices market size has grown strongly in recent years. It will grow from $1.98 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to improvements in device portability and compact design, rising awareness of respiratory therapy options, increased adoption of noninvasive airway clearance methods, and the expansion of respiratory device distribution networks.

The cough assist devices market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for patient-centric and user-friendly devices, rising medical tourism for cost-effective respiratory treatments, growing adoption in rehabilitation centers, and expanding use in pediatric care. Major trends during this period include the development of hybrid devices, integration of smart sensors, portable and compact designs, AI-driven performance monitoring, and customizable patient profiles.

The increasing incidence of respiratory diseases is expected to propel the growth of the cough assist devices market going forward. Respiratory diseases are medical conditions affecting the lungs and respiratory system, often resulting in difficulty breathing. The rise in respiratory diseases is largely driven by increasing air pollution from vehicle emissions and industrial activities. Cough assist devices support respiratory care by helping patients clear airway secretions effectively, improving lung function, reducing infection risk, and enhancing overall quality of life. For instance, in February 2025, the Joint Strategic Needs Assessment, a UK-based community health center, reported that 13,573 people (8.1%) in the Blackpool ICB area were living with asthma in 2023-24, up from 7.9% in 2022-23 and above the England average of 6.5%. Therefore, the rising incidence of respiratory diseases is driving the growth of the cough assist devices market.

Prominent companies in the market are focusing on innovations such as integrated cough assist ventilators to improve patient outcomes and optimize respiratory care. Integrated cough assist ventilators combine ventilation and cough assistance in a single device, enabling patients with respiratory muscle weakness to clear airway secretions efficiently while maintaining continuous ventilatory support. For instance, in June 2024, React Health, a US-based sleep and respiratory device manufacturer, introduced IntelliPAP for its V Home, V+ Pro, V+C, and VC+ Pro ventilators. The feature integrates cough assist therapy into ventilation, reducing therapy time from minutes to seconds, maintaining patient safety, and enhancing comfort. Features such as high-flow therapy and responsive leak compensation further streamline airway clearance and increase utilization in hospital and home settings.

In January 2025, ActiGraph, a US-based provider of physical activity and sleep-monitoring solutions, partnered with Hyfe Inc. to integrate AI-powered cough detection into its LEAP wearable device for clinical research. This collaboration provides a continuous, privacy-preserving digital health tool that enables long-term, objective monitoring of cough alongside other vital health metrics, supporting both clinical research and improved patient care. Hyfe Inc. specializes in AI-powered cough-monitoring technologies, including cough assist systems.

Major players in the cough assist devices market are McKesson Corporation, Air Liquide Medical Systems S.A.S., Medtronic plc, Koninklijke Philips N.V., Baxter International Inc., ResMed Inc., Hill-Rom Holdings Inc., ICU Medical Inc., Aetna Inc., ABM Respiratory Care Inc., Ventec Life Systems Inc., Progetti S.r.l., O-Two Medical Technologies Inc., WestCare Medical Ltd., Nidek Medical Products Inc., United Hayek Industries Inc., HealthyBlue Inc., Dima Italia S.r.l., Triumph Medical Services Inc., and Genotronics Medical Inc.

North America was the largest region in the cough assist devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cough assist devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cough assist devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Cough assist devices are medical tools designed to help individuals with weakened respiratory muscles by simulating an effective cough to remove mucus and secretions from the airways. They function by delivering a controlled positive pressure breath into the lungs, followed by a rapid shift to negative pressure, producing airflow that replicates a strong natural cough.

The primary types of cough assist devices include automatic cough assist devices and manual cough assist devices. Automatic cough assist devices provide airway clearance without requiring manual adjustment of settings. These devices encompass mechanical cough assist machines, high-frequency chest wall oscillation devices, and in-exsufflation systems, and cater to pediatric, adult, and geriatric patients. Key end users include hospitals, clinics, ambulatory care centers, and home care settings.

The cough assist devices market research report is one of a series of new reports that provides cough assist devices market statistics, including cough assist devices industry global market size, regional shares, competitors with a cough assist devices market share, detailed cough assist devices market segments, market trends and opportunities, and any further data you may need to thrive in the cough assist devices industry. This cough assist devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cough assist devices market consists of sales of mouthpieces and face masks, humidifiers, power adapters, tubing and circuit kits, and bacterial/viral filters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.